MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 97 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $24,000 | +41.2% | 9,484 | +8.8% | 0.00% | +100.0% |
| Q1 2020 | $17,000 | +325.0% | 8,713 | +385.9% | 0.00% | – |
| Q4 2019 | $4,000 | -33.3% | 1,793 | -53.4% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 3,846 | +96.9% | 0.00% | -100.0% |
| Q2 2019 | $8,000 | -11.1% | 1,953 | -12.1% | 0.00% | 0.0% |
| Q1 2019 | $9,000 | -71.9% | 2,222 | -79.5% | 0.00% | -66.7% |
| Q4 2018 | $32,000 | +255.6% | 10,819 | +1082.4% | 0.00% | +200.0% |
| Q3 2018 | $9,000 | – | 915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |